You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Related Research Videos on Diabetes Health TV
Nuevas Pequeñas Molécula Drogas Para El Tipo 2 - Ensayos Humanos En Curso
Continuous Glucose Monitoring with DEXCOM's "The Seven"
Nipro Diabetes Systems Introduces The Amigo®
Popular FDA Articles
Highly Recommended FDA Articles
Animas Corporation, a division of Johnson & Johnson that manufactures insulin pumps, has been reprimanded by the FDA for not reporting serious problems resulting from use of its equipment. The parent company was warned that it could face fines and more for selling faulty insulin pumps and failing to disclose serious injuries to diabetic patients who used the OneTouch Ping and 2020 insulin pumps. According to reports, J&J continued to sell the pumps even after the company knew that some had failed.
1 comment - Jan 29, 2012 -
The FDA has given Roche the go-ahead to market its Accu-Chek® Nano SmartView blood glucose monitoring system. The Nano, which uses Accu-Chek SmartView test strips, will be available to US consumers within the first half of this year. It is part of the same product line as the Accu-Chek Aviva Nano and Accu-Chek Performa Nano systems, which Roche has already launched in several overseas markets.
3 comments - Jan 22, 2012 -
A dietary supplement, also known as a food supplement or nutritional supplement, contains a "dietary ingredient" intended to supplement the diet by providing an element that might not otherwise be consumed. "Dietary ingredients" include vitamins, minerals, herbs and other botanicals, amino acids, and substances such as enzymes, organ tissues, and metabolites. Dietary supplements, which may be extracts or concentrates, come in many forms, including tablets, capsules, soft gels, gelcaps, liquids, powders, and bars.
0 comments - Jan 7, 2012 -
Spring Health Solutions, Inc., has released an instructional video describing its Spring Universal Infusion Set, recently approved by the FDA and Health Canada. The video, at www.SpringUniversal.com, is designed to help consumers properly use the product.
0 comments - Jan 4, 2012 -
Will the federal government kill the artificial pancreas? The Juvenile Diabetes Research Foundation (JDRF) is raising the alarm over FDA guidelines that could stifle the technology necessary for the development of an artificial pancreas.
12 comments - Dec 8, 2011 -
I want to thank you all for the many comments that you have posted. As I said in the article, it does bother me that so many promises have been made and not kept regarding a cure. This has resulted in people just giving up hope and coming to believe that there will never be a cure for diabetes. Such promises are still being made today.
20 comments - Sep 13, 2011 -
US Action Follows Stop-Ship That Began in June
1 comment - Aug 27, 2011 -
The Internet allows consumers to shop for deals on anything imaginable, even prescription drugs. The economic struggles that many currently face, paired with the increasing cost of healthcare and prescription drugs, have created an environment in which counterfeit drug makers can prosper.
1 comment - Jul 7, 2011 -
The U.S. Food and Drug Administration has said that starting on November 18, 2011, it will restrict retail pharmacy sales of three diabetes drugs manufactured by GlaxoSmithKline: the stand-alone Avandia (rosiglitazone) and the combination drugs Avandamet (rosiglitazone and metformin) and Avandaryl (rosiglitazone and glimepiride).
0 comments - Jun 11, 2011 -
"Nutrient Depletions" is a new smart phone app that allows users to see which of their prescription medications may be draining nutrients from their body. The app, available at iTunes stores for $1.99, works on Apple's iPhone, iTouch, and iPad products.
4 comments - May 31, 2011 -
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.